Make ABN Newswire your homepage | Add to Favourites
 CHINESE SIMPLE   CHINESE TRAD     JAPANESE     KOREAN
 ENGLISH    ARABIC    EUROPE
 
  Home    |   Media Partners    |    About Us   |   Contact Us
 
Home News
 

Melbourne, Jan 23, 2008 (ABN Newswire) - The Directors of Solagran Limited are pleased to announce that Ms Victoria Gorbacheva, the Business Development & Marketing Director of Berlin-Chemie/Menarini Pharma GmbH, part of the international Menarini Pharmaceutical group, is visiting Melbourne to further progress ongoing discussions in relation to the licencing, marketing and distribution of Ropren


About SOLAGRAN LIMITED

Solagran is a biotechnology company with a portfolio of higly effective, low side effect, natural pharmaceuticals that it obtains from gree tree foliage. Its patented technology enables the extraction of the live elements of trees in a way that both preserves and amplifies their biological activity.


  Related Companies

>>>    SOLAGRAN LIMITED

 

 
 
Solagran Limited (ASX:SLA) Ropren Licencing, Marketing and Distribution Announcement
 
SOLAGRAN LIMITED
2008.04.22  12:48
Solagran Limited (ASX:SLA) Update on Ropren Production and Marketing In Russia

2008.04.02  09:46
Solagran (ASX:SLA) Announce Marketing Strategy Details For Ropren In Russia

2008.03.27  12:46
Solagran Opens Commercial Scale Plant for Pharmaceutical Grade Polyprenols

2008.03.27  12:40
Solagran Limited (ASX:SLA) Announce Formal Opening Of Russian Facility

2008.03.19  11:37
Solagran Limited (ASX:SLA) Announce Approval Of ROPREN for Sale In Russia

 
Asia Business News
Submit Press
News Alerts by Email
Home | Contact Us | About Us
Copyright 2008 Asia Business News Ltd.